CMS recently extended to Oct. 6 the application deadline for hospitals interested in testing the first of four bundled payment models. It will be a while until you find out while which system the agency ultimately chooses, but this is certain - you will be affected.
CMS recently extended to Oct. 6 the application deadline for hospitals interested in testing the first of four bundled payment models. It will be a while until you find out while which system the agency ultimately chooses, but this is certain - you will be affected.
Three models are retrospective bundling systems, and the fourth is prospective. Even if your hospital isn’t a testing ground, knowing the basics of each model could save you future confusion.
Model 1: This model defines an episode-of-care as an inpatient stay in the general acute-care hospital. CMS would reimburse you for your services separately under the Medicare Physician Fee Schedule, and hospitals would receive a discounted payment based on Inpatient Prospective Payment System payment rates. If any gains from improved coordination of care occur, hospitals and providers would share them.
Model 2: As with Model 1, Model 2 includes the inpatient stay, but it would also encompass post-acute care ending at either 30 or 90 days after discharge. Medicare would pay a lump payment for your services in post-acute provider care, related readmissions, and other services, such as durable medical equipment, clinical lab services, prosthetics, Part B drugs, etc. To get a target price, Medicare would discount an amount based on the fee-for-service payments you usually receive for the episode. Payments would be doled out at these normal fee-for-service rates, and Medicare would reconcile them against the target price.
Model 3: This model mirrors Model 2 except episodes-of-care begin at inpatient-stay discharge and ends no sooner than 30-days post-discharge.
Model 4: With this prospective payment model, CMS would make a single, bundled payment to the hospital. It encompasses all inpatient-stay services provided by the hospital and all providers. You would be required to submit “no-pay” claims to Medicare, and the hospital would reimburse you out of its overall bundled payment.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.